SE9603304D0 - Process for purifying a compound - Google Patents

Process for purifying a compound

Info

Publication number
SE9603304D0
SE9603304D0 SE9603304A SE9603304A SE9603304D0 SE 9603304 D0 SE9603304 D0 SE 9603304D0 SE 9603304 A SE9603304 A SE 9603304A SE 9603304 A SE9603304 A SE 9603304A SE 9603304 D0 SE9603304 D0 SE 9603304D0
Authority
SE
Sweden
Prior art keywords
polymeric material
surfactant
hydrophobic
amphiphilic compound
atherosclerosis
Prior art date
Application number
SE9603304A
Other languages
English (en)
Inventor
Josefine Persson
Lena Nystroem
Folke Tjerneld
Hans Ageland
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Priority to SE9603304A priority Critical patent/SE9603304D0/sv
Publication of SE9603304D0 publication Critical patent/SE9603304D0/sv
Priority to US08/924,869 priority patent/US6107467A/en
Priority to PCT/SE1997/001502 priority patent/WO1998011127A1/en
Priority to PT97939315T priority patent/PT954524E/pt
Priority to DE69720786T priority patent/DE69720786T2/de
Priority to ES97939315T priority patent/ES2197361T3/es
Priority to JP10513557A priority patent/JP2001500154A/ja
Priority to EP97939315A priority patent/EP0954524B1/en
Priority to AU41430/97A priority patent/AU729536B2/en
Priority to DK97939315T priority patent/DK0954524T3/da
Priority to AT97939315T priority patent/ATE236925T1/de
Priority to CA002265929A priority patent/CA2265929A1/en
Priority to NZ334589A priority patent/NZ334589A/xx
Priority to NO19991208A priority patent/NO323217B1/no
Priority to US09/571,683 priority patent/US6767994B1/en
Priority to US10/863,456 priority patent/US7193056B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9603304A 1996-09-11 1996-09-11 Process for purifying a compound SE9603304D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9603304A SE9603304D0 (sv) 1996-09-11 1996-09-11 Process for purifying a compound
US08/924,869 US6107467A (en) 1996-09-11 1997-09-05 Process for purifying a compound
NZ334589A NZ334589A (en) 1996-09-11 1997-09-08 Aqueous two-phase system for purifying apolipoproteins
JP10513557A JP2001500154A (ja) 1996-09-11 1997-09-08 アポリポ蛋白質の精製方法および該方法で使用する化合物
DK97939315T DK0954524T3 (da) 1996-09-11 1997-09-08 Fremgangsmåde til rensning af apolipoproteiner
DE69720786T DE69720786T2 (de) 1996-09-11 1997-09-08 Verfahren zur reinigung von apolipoproteinen
ES97939315T ES2197361T3 (es) 1996-09-11 1997-09-08 Procedimiento para purificar apolipoproteinas.
PCT/SE1997/001502 WO1998011127A1 (en) 1996-09-11 1997-09-08 A process for purifying apolipoproteins and a composition for use in the process
EP97939315A EP0954524B1 (en) 1996-09-11 1997-09-08 Process for purifying apolipoproteins
AU41430/97A AU729536B2 (en) 1996-09-11 1997-09-08 A process for purifying apolipoproteins and a composition for use in the process
PT97939315T PT954524E (pt) 1996-09-11 1997-09-08 Processo para purificar apolipoproteinas
AT97939315T ATE236925T1 (de) 1996-09-11 1997-09-08 Verfahren zur reinigung von apolipoproteinen
CA002265929A CA2265929A1 (en) 1996-09-11 1997-09-08 A process for purifying apolipoproteins and a composition for use in the process
NO19991208A NO323217B1 (no) 1996-09-11 1999-03-11 Fremgangsmate for rensing av apolipoprotein A eller apolipoprotein E.
US09/571,683 US6767994B1 (en) 1996-09-11 2000-05-16 Process for purifying a compound
US10/863,456 US7193056B2 (en) 1996-09-11 2004-06-08 Process for purifying a compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603304A SE9603304D0 (sv) 1996-09-11 1996-09-11 Process for purifying a compound

Publications (1)

Publication Number Publication Date
SE9603304D0 true SE9603304D0 (sv) 1996-09-11

Family

ID=20403846

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603304A SE9603304D0 (sv) 1996-09-11 1996-09-11 Process for purifying a compound

Country Status (2)

Country Link
US (3) US6107467A (sv)
SE (1) SE9603304D0 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603303D0 (sv) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603304D0 (sv) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
MXPA04002848A (es) * 2001-09-28 2005-06-06 Esperion Therapeutics Inc Prevencion y tratamiento de restenosis por administracion local de medicamento.
NZ537006A (en) * 2002-05-17 2008-01-31 Esperion Therapeutics Inc The use of apolipoprotein A-I Milano, for the manufacture ofa composition for treating preventing or reducing ischemic reperfusion injury in a tissue or organ
SE0202552D0 (sv) * 2002-08-27 2002-08-27 Amersham Biosciences Ab Recovery of plasmids in an aqueous two-phase system
US20040104156A1 (en) * 2002-11-26 2004-06-03 Kolesinski Henry S. Chromatographic separation processes and apparatus
CN1870894B (zh) * 2003-10-20 2011-08-10 埃斯普里昂治疗公司 用于治疗和预防急性冠状动脉综合征的药物制剂、方法和给药方案
WO2005097206A2 (en) * 2004-04-06 2005-10-20 Cedars-Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
US20070128013A1 (en) * 2005-12-01 2007-06-07 Grant Hanson Apparatus protecting vehicle with bucket when bucket strikes fixed object
US20070254832A1 (en) * 2006-02-17 2007-11-01 Pressler Milton L Methods for the treatment of macular degeneration and related eye conditions
EP2243546A1 (en) * 2009-04-20 2010-10-27 Imperial Innovations Limited Aqueous solvents for hydrocarbons and other hydrophobic compounds
US20130137628A1 (en) 2010-05-11 2013-05-30 Esperion Therapeutics, Inc. Dimeric Oxidation-Resistant Apolipoprotein A1 Variants
BR112016025470A2 (pt) 2014-05-02 2017-08-15 Cerenis Therapeutics Holding S A ?hdl terapêutico?

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6196998A (ja) 1984-10-16 1986-05-15 Mitsubishi Chem Ind Ltd ヒトアポリポプロテインａ−ｉ様蛋白の産生方法
SE462100B (sv) 1985-08-08 1990-05-07 Perstorp Ab Komposition och dess anvaendning i ett tvaa- eller flerfassystem
EP0262651A3 (en) 1986-09-30 1990-06-20 Union Carbide Corporation Isolation of enzyme values from solution
GB8625435D0 (en) 1986-10-23 1986-11-26 Erba Farmitalia Human apolipoprotein ai
GB8712540D0 (en) 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
JP2606228B2 (ja) 1987-09-18 1997-04-30 三菱化学株式会社 ヒトプロアポリポプロテインａ−ｉ様蛋白の産生法
JP2561674B2 (ja) 1987-10-06 1996-12-11 三菱化学株式会社 蛋白質の産生方法
IT1229996B (it) 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
SE9103701D0 (sv) 1991-12-13 1991-12-13 Kabi Pharmacia Ab Apolipoprotein
EP0574050A1 (en) 1992-05-19 1993-12-15 Gist-Brocades N.V. Large scale separation and purification of fermentation product
ATE171192T1 (de) 1992-06-12 1998-10-15 Innogenetics Nv Peptide und proteine, verfahren zur ihren herstellung und die verwendung als cholesterol- annehmer
SE9203753D0 (sv) 1992-12-11 1992-12-11 Kabi Pharmacia Ab Expression system for producing apolipoprotein ai-m
JP3491917B2 (ja) 1993-02-05 2004-02-03 メビオール株式会社 熱可逆性ハイドロゲル材料
WO1996004556A1 (en) * 1994-08-01 1996-02-15 Hsu James T Lipoprotein cholesterol assays
ATE355363T1 (de) 1995-01-27 2006-03-15 Genencor Int Verfahren zur extraktion von enzymen unter verwendung von tensiden
SE9500778D0 (sv) 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE9603304D0 (sv) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
US6006193A (en) * 1996-12-18 1999-12-21 Gibson; Kenneth U. Computer executable workflow control system
US6536935B2 (en) * 1997-07-23 2003-03-25 Atarum Institute Computerized system for market-based constraint optimization
US5999910A (en) * 1997-10-06 1999-12-07 Fmr Corp. Processing a workflow item
US6772131B1 (en) * 1999-02-01 2004-08-03 American Management Systems, Inc. Distributed, object oriented global trade finance system with imbedded imaging and work flow and reference data
US6611822B1 (en) * 1999-05-05 2003-08-26 Ac Properties B.V. System method and article of manufacture for creating collaborative application sharing
US6640249B1 (en) * 1999-08-31 2003-10-28 Accenture Llp Presentation services patterns in a netcentric environment

Also Published As

Publication number Publication date
US6107467A (en) 2000-08-22
US20040225120A1 (en) 2004-11-11
US7193056B2 (en) 2007-03-20
US6767994B1 (en) 2004-07-27

Similar Documents

Publication Publication Date Title
SE9603303D0 (sv) Process for purifying a protein
SE9603304D0 (sv) Process for purifying a compound
ATE452870T1 (de) (meth)acrylsaeurekristall und verfahren zur herstellung und aufreinigung von waessriger (meth)acrylsaeure
CA1253668A (en) Method of separation of sugars and concentrated sulfuric acid
ATE189204T1 (de) Verfahren zur herstellung von cyclischen estern
DE69427357D1 (de) Verfahren zur herstellung von zusammensetzungen zur reinigung von halbleiterverfahrensgasen zur entfernung von lewis-säure und oxydationsmittelverunreinigungen
EP1132365A4 (en) AZEOTROPIC MIXTURE OF 1,1,1,3,3-PENTAFLUORO-PROPANE AND 1,1,1-TRIFLUORO-3-CHLORO-2-PROPENE, A METHOD FOR THE SEPARATION AND CLEANING OF THE SAME, AND A METHOD FOR THE PRODUCTION OF 1,1,1,3 , 3-PENTAFLUOROPROPAN AND 1,1,1-TRIFLUORO-3-CHLORO-PROPENE
KR890014439A (ko) 지방산의 연속적인 에스테르화 방법
ATE472011T1 (de) Verfahren zur herstellung von furfural, essigsäure und ameisensäure aus verbrauchter zellstoffkochlauge
DK0792281T3 (da) Proces til oprensning af faktor VIII
ATE218526T1 (de) Verfahren zur herstellung von xylitol
DK0954524T3 (da) Fremgangsmåde til rensning af apolipoproteiner
ATE86978T1 (de) Verfahren zur herstellung von 3,5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer.
ATE306564T1 (de) Verfahren zur aufreinigung von maltose
HUP0003518A2 (hu) Eljárás formaldehid-tartalmú elegyek kezelésére
EP1525044B8 (en) Method of purifying air, apparatus for purifying air and building provided with this apparatus
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
DE69738397D1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
DE60117525D1 (de) Verfahren zur herstellung von laktonen
WO2001010390A3 (de) Sonnenschutzmittel alkoxylierte carbonsäureester enthaltend
ATE395428T1 (de) Verfahren zur isolierung und reinigung von lipidezellwandkomponenten
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
DE59302812D1 (de) Verfahren zur Herstellung von reinem 2,5-Dichlorpyridin sowie Gewinnung des als Nebenprodukt anfallenden 2,3-Dichlorpyrdins
ATE241585T1 (de) Verfahren zur gewinnung von pivalinsäure aus abfallreaktionsgemischen
ATE302178T1 (de) Verfahren zur herstellung von spezifikationsgerechtem phthalsäureanhydrid